Avenda Health AI Prostate Cancer Planning Software vs Neosoma Platform

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Avenda Health AI Prostate Cancer Planning Software

by Avenda Health

Neosoma Platform

by Neosoma

AI Verdict

These tools are adjacent competitors, both offering AI-powered clinical decision support and radiology/imaging AI for oncology. However, Avenda Health AI specializes in prostate cancer planning, generating 3D cancer maps to aid in various prostate cancer treatments, while Neosoma Platform focuses on neuro-oncology, providing automated tumor mapping and lesion tracking for brain metastases and gliomas.

Choose Avenda Health AI Prostate Cancer Planning Software if…

Choose Avenda Health AI Prostate Cancer Planning Software if you need highly precise, 3D mapping of prostate cancer for personalized treatment planning across the entire care continuum, including active surveillance, focal therapy, surgery, and radiotherapy. It excels at improving the identification of tumor extent, predicting extracapsular extension risk, and aiding in surgical planning for nerve-sparing procedures.

View Avenda Health AI Prostate Cancer Planning Software →

Choose Neosoma Platform if…

Choose Neosoma Platform if you specialize in neuro-oncology and require an AI-powered solution for automated tumor mapping, longitudinal lesion tracking, and real-time insights for brain metastases and gliomas. This platform is ideal for multidisciplinary teams, researchers, and clinical trials, offering PACS integration and interoperability with various treatment planning systems.

View Neosoma Platform →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Avenda Health AI Prostate Cancer Planning Software	Neosoma Platform
Pricing	Contact for pricing	Volume-based
Deployment	Cloud-based platform	Cloud
BAA Available	Unknown	Yes AI-estimated
FDA Status	Yes AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools are cloud-based and offer features that suggest good usability for their respective specialties. Avenda Health's Unfold AI generates 3D cancer maps and supports data export to compatible systems, while Neosoma Platform offers interactive 3D/2D visualizations, smart editing tools, and PACS integration. Without direct user feedback or more detailed feature comparisons on ease of use, it's difficult to definitively pick a winner.

Clinical Value

Tie

Both tools demonstrate strong clinical value within their specific oncology domains. Avenda Health's Unfold AI significantly improves the identification of prostate tumor extent and aids in personalized treatment planning. Neosoma Platform provides automated tumor mapping and longitudinal lesion tracking for neuro-oncology, offering real-time insights crucial for managing brain metastases and gliomas. Both are FDA-cleared, indicating recognized clinical utility.

Pricing & Value

Neosoma Platform

Neosoma Platform offers transparent volume-based pricing, allowing multiple team members access without additional seat licenses, which can be more cost-effective for larger teams. Avenda Health's pricing requires direct contact, and while a new CPT code is available for reimbursement, the initial transparency and potential for broader team access give Neosoma an edge in value.

Enterprise Readiness

Neosoma Platform

Neosoma Platform explicitly mentions PACS integration, SOC2 Type II certification, and interoperability with various treatment planning systems (Eclipse, MIM, Gamma Plan, Stealth), indicating a strong focus on enterprise integration and security. Avenda Health also states HIPAA compliance and data export capabilities, but Neosoma's broader set of explicit enterprise-focused features suggests a higher degree of readiness for large-scale deployments.

Innovation

Tie

Both tools showcase significant innovation in their respective fields. Avenda Health's Unfold AI uses AI to create precise 3D cancer maps for prostate cancer, improving tumor extent identification. Neosoma Platform provides automated, real-time insights and longitudinal tracking for neuro-oncology, which is highly innovative for managing complex brain conditions. Both leverage advanced AI for critical clinical decision support.

Support & Docs

Tie

Neither product's provided information details their specific support offerings or documentation availability. While both are FDA-cleared and operate in critical clinical areas, implying a certain level of support, there isn't enough information to differentiate between them on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Avenda Health AI Prostate Cancer Planning Software	Neosoma Platform
Name	Avenda Health AI Prostate Cancer Planning Software	Neosoma Platform
Company	Avenda Health	Neosoma
Description	Avenda Health's Unfold AI is an FDA-cleared, AI-based decision support software that creates 3D cancer maps from patient data to precisely visualize prostate cancer extent, aiding physicians in treatment planning and decision-making for personalized care.	The Neosoma Platform is a cloud-based, FDA-cleared AI tool for neuro-oncology, providing automated tumor mapping, lesion tracking, and real-time insights for brain metastases and gliomas.
Target Cancer Type	Prostate Cancer	Brain metastases and gliomas (neuro-oncology)
Key Features (Examples)	Generates 3D Cancer Estimation Maps (CEM), aids in surgical planning and treatment decision-making, predicts extracapsular extension (ECE) risk.	Automated DICOM study analysis, longitudinal lesion tracking, interoperable with treatment planning systems (Eclipse, MIM, Gamma Plan, Stealth).
SOC2 Certified	Not specified	yes

Videos

Demos, reviews, and walkthroughs featuring Avenda Health AI Prostate Cancer Planning Software and Neosoma Platform.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems?

Avenda Health's Unfold AI integrates patient-specific data from imaging, biopsies, and pathology to generate 3D cancer maps and can export data to compatible interventional or biopsy systems, as well as EHR systems. Neosoma Platform integrates with PACS for automated DICOM study analysis and offers one-click deep linking to jump from PACS to Neosoma's system. It is also interoperable with radiation treatment and surgical planning systems like Eclipse, MIM, Gamma Plan, and Stealth.

What is the accuracy and sensitivity of each tool in identifying and tracking tumors?

Avenda Health's Unfold AI has demonstrated improved identification of tumor extent with over 98% sensitivity in studies, and a 97% sensitivity rate in detecting cancer size and location. It has also shown an 84.7% balanced accuracy in AI-assisted cancer margins, significantly outperforming conventional methods. Neosoma HGG, for high-grade gliomas, has shown a 95.5% accuracy rate in measuring tumor volume at different points during a patient's treatment course.

Given their specialized focus, how do these tools fit within a multi-disciplinary care team?

Avenda Health's Unfold AI is designed for prostate cancer care, aiding urologists, radiologists, and oncologists in treatment planning across the continuum of care, including active surveillance, focal therapy, surgery, and radiotherapy. Neosoma Platform is built for the multidisciplinary neuro-oncology clinical team, researchers, and clinical trials, supporting radiology, radiation oncology, medical oncology, and surgical workflows, as well as tumor board decision-making for brain metastases and gliomas.

What is the typical learning curve for physicians and clinical staff to become proficient with each platform?

Neosoma Platform is designed for quick adoption with an intuitive, web-based interface that allows users to be up and running in just a few minutes. Information regarding the specific learning curve for Avenda Health's Unfold AI is not explicitly detailed, but its integration with existing systems suggests a focus on streamlining workflow.

Are there audit-trail features available to track usage and changes made within the software?

While specific details on audit-trail features are not extensively described for either tool, robust cloud security frameworks often include cloud logging and Security Information and Event Management (SIEM) for continuous monitoring and audit requirements. Neosoma's SOC2 Type II certification also implies comprehensive logging and monitoring capabilities.

How do these tools support multi-site rollouts for larger healthcare systems?

Avenda Health's Unfold AI is in use at major academic centers and community practices nationwide, indicating its capability for multi-site deployment. Neosoma's cloud-based platform can process a virtually unlimited number of patient MRIs and allows multiple team members to have logins, suggesting scalability for larger healthcare systems.